Please assess the completion status of the following clinical trial:

Trial Title: The EFFect of hIgh Dose ClopIdogrel treatmENT in Patients With Clopidogrel Resistance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The patients; who have planned elective PCI and have had written informed consent for participation to study.~* Age\>18 year-old,~* The native coronary artery;lesion with narrowing \>=70%~Exclusion Criteria:~* Patients have allergy for ASA, Clopidogrel and heparin~* Patients who performed primary PCI~* Patients with acute coronary syndrome~* Patients with have a history of PCI and use clopidogrel~* Patients on warfarin therapy~* Patients who have bleeding diathesis, or have high risk for bleeding.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- high dose clopidogrel (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).